Gastric Bypass

A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.

Adults with obesity who underwent bariatric surgery were less likely to develop pancreatic cancer than those who with obesity who did not have bariatric surgery, researchers reported.

Patients with severe obesity undergoing Roux-en-Y gastric bypass for weight loss demonstrated greater reductions in blood lipids at 6 weeks vs. those on a very low-energy diet, according to study results in JAMA Surgery.

Women with obesity who undergo bariatric surgery and have higher levels of insulin have a lower risk for breast cancer than women who do not undergo surgery, according to findings published in JAMA Surgery.

Adults who received tirzepatide experienced greater weight loss than those who received placebo, regardless of each patient’s length of history of obesity, according to a post-hoc analysis of four SURMOUNT trials.

Adults with type 2 diabetes have a reduction in overall health care costs after bariatric surgery, regardless of whether they underwent gastric bypass or sleeve gastrectomy, according to study findings published in Obesity.

Most adults with type 2 diabetes and obesity who undergo gastric bypass achieve continued diabetes remission, even after weight regain, according to study findings published in the Journal of the American College of Surgeons.

Adults who initiated once-weekly semaglutide after not responding to bariatric surgery lost a similar amount of weight as those without a history of bariatric surgery, according to study findings published in Obesity.

BOSTON — Patients with metabolic dysfunction-associated steatotic liver disease who underwent bariatric surgery lost less weight over 5 years than those without MASLD, according to research presented at The Liver Meeting.